Scancell Holdings (GB:SCLP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Scancell Holdings Plc, a developer of novel immunotherapies, has announced that CFO Sath Nirmalananthan will present at the Sachs 10th Annual Oncology Innovation Forum on May 31, 2024. Nirmalananthan is set to participate in a panel discussing the future of cell therapies and cancer vaccines and will present Scancell’s progress in trials for their innovative cancer vaccine SCIB1 and the Modi-1 monotherapy. The company aims to showcase its advancements and proprietary technology in the field of immunotherapy at the prestigious event.
For further insights into GB:SCLP stock, check out TipRanks’ Stock Analysis page.